As of 28 Aug 2026, Aspira Pathlab & Diagnostics Ltd share price is ₹89.75. The stock opened at ₹89.75 and had closed at ₹88.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹49.00 and a high of ₹135.88. In terms of performance, Aspira Pathlab & Diagnostics Ltd share price has increased by 48.35% over the past six months and has increased by 39.56% over the last year.
Aspira Pathlab Charts
Aspira Pathlab & Diagnostics Ltd Overview
About Aspira Pathlab
Aspira Pathlab & Diagnostics is engaged in the business of running, owning, managing and administering Diagnostics Centres. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.
Aspira Pathlab & Diagnostics Ltd Historical Performance
Aspira Pathlab & Diagnostics Ltd Fundamental Analysis
Aspira Pathlab & Diagnostics Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 6.29 | 6.66 | 5.25 | 8.23 | 5.36 |
| EBITDA | 0.46 | -0.19 | -1.08 | 2.34 | 0.93 |
| Net Profit | -0.04 | -0.69 | -1.56 | 1.84 | 0.47 |
| EPS | -0.04 | -0.67 | -1.52 | 1.78 | 0.46 |
Aspira Pathlab & Diagnostics Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 29.07 |
| MACD | -5.42 |
| 20-Day SMA | 101.56 |
Aspira Pathlab & Diagnostics Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Aspira Pathlab & Diagnostics Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,800.00+0.38% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,009.00+0.40% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹915.65+0.20% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aspira Pathlab & Diagnostics Ltd today is ₹89.75 on NSE and ₹89.75 on BSE.
- The 52-week high of Aspira Pathlab & Diagnostics Ltd is ₹135.88, while the 52-week low is ₹49.00.
- The current market capitalisation of Aspira Pathlab & Diagnostics Ltd is approximately ₹92 crore.
- The P/E (Price-to-Earnings) ratio of Aspira Pathlab & Diagnostics Ltd is 24.46. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aspira Pathlab & Diagnostics Ltd is 8.11. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Aspira Pathlab & Diagnostics Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Aspira Pathlab & Diagnostics Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Aspira Pathlab & Diagnostics Ltd has delivered a return of approximately 115.54%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aspira Pathlab & Diagnostics Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 46.58% promoters, 0.00% FIIs, 0.00% DIIs, and 40.70% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
